A.
Baron
T.
Migita
D.
Tang
M.
Loda
(2004)
ArticleTitleFatty acid synthase: a metabolic oncogene in prostate cancer?
J. Cell. Biochem.
91
47–53
Occurrence
Handle10.1002/jcb.10708
Occurrence
Handle1:CAS:528:DC%2BD2cXlvV2gsQ%3D%3D
Occurrence
Handle14689581
Article
CAS
PubMed
Google Scholar
P.A.
Boekhorst
B.
Lowenberg
J.
van Kapel
K.
Nooter
P.
Sonneveld
(1995)
ArticleTitleMultidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia
Leukemia
9
1025–1031
Occurrence
Handle7541095
PubMed
Google Scholar
J.
Boren
M.
Cascante
S.
Marin
et al.
(2001)
ArticleTitleGleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells
J. Biol. Chem.
276
37747–37753
Occurrence
Handle1:CAS:528:DC%2BD3MXotFOrsbY%3D
Occurrence
Handle11489902
CAS
PubMed
Google Scholar
L.G.
Boros
J.
Puigjaner
M.
Cascante
et al.
(1997)
ArticleTitleOxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation
Cancer Res.
57
4242–4248
Occurrence
Handle1:CAS:528:DyaK2sXmsFChu74%3D
Occurrence
Handle9331084
CAS
PubMed
Google Scholar
L.G.
Boros
S.
Bassilian
S.
Lim
W.N.
Lee
(2001a)
ArticleTitleGenistein inhibits non-oxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth
Pancreas
22
1–7
Occurrence
Handle10.1097/00006676-200101000-00001
Occurrence
Handle1:STN:280:DC%2BD3M7hs1aisQ%3D%3D
Article
CAS
Google Scholar
L.G.
Boros
K.
Lapis
B.
Szende
et al.
(2001b)
ArticleTitleWheat germ extract decreases glucose uptake and RNA ribose formation but increases fatty acid synthesis in MIA pancreatic adenocarcinoma cells
Pancreas
23
141–147
Occurrence
Handle10.1097/00006676-200108000-00004
Occurrence
Handle1:STN:280:DC%2BD38%2FislGqsA%3D%3D
Article
CAS
Google Scholar
L.G.
Boros
W.N.
Lee
V.L.
Go
(2002a)
ArticleTitleA metabolic hypothesis of cell growth and death in pancreatic cancer
Pancreas
24
26–33
Occurrence
Handle10.1097/00006676-200201000-00004
Article
Google Scholar
L.G.
Boros
M.
Cascante
W.N.
Lee
(2002b)
ArticleTitleMetabolic profiling of cell growth and death in cancer: applications in drug discovery
Drug Discov. Today
7
364–372
Occurrence
Handle10.1016/S1359-6446(02)02179-7
Occurrence
Handle1:CAS:528:DC%2BD38XhvVWhsbg%3D
Article
CAS
Google Scholar
L.G.
Boros
D.J.
Brackett
G.G.
Harrigan
(2003a)
ArticleTitleMetabolic biomarker and kinase drug target discovery in cancer using stable isotope-based dynamic metabolic profiling (SIDMAP)
Curr. Cancer Drug Targets
3
445–453
Occurrence
Handle10.2174/1568009033481769
Occurrence
Handle1:CAS:528:DC%2BD3sXhtVSmurjI
Article
CAS
Google Scholar
L.G.
Boros
M.P.
Steinkamp
J.C.
Fleming
W.N.
Lee
M.
Cascante
E.J.
Neufeld
(2003b)
ArticleTitleDefective RNA ribose synthesis in fibroblasts from patients with thiamine-responsive megaloblastic anemia (TRMA)
Blood
102
3556–3561
Occurrence
Handle10.1182/blood-2003-05-1537
Occurrence
Handle1:CAS:528:DC%2BD3sXptVymtro%3D
Article
CAS
Google Scholar
L.G.
Boros
M.
Cascante
W.-N.P.
Lee
(2003c)
Stable isotope-based dynamic metabolic profiling in disease and health
G.G.
Harrigan
R.
Goodacre
(Eds)
Metabolic profiling: its role in biomarker discovery and gene function analysis
Kluwer Academic Publishers
Boston
Google Scholar
Boros L.G. (2004). Metabolic profile of inflammatory breast cancer: aiding diagnosis and treatment. George Washington University and the IBC Research Foundation co-sponsored “IBC Mini Symposium” hosted by George Washington University: http://www.ibcresearch.org/ibcminisymposium/
S.W.
Cowan-Jacob
V.
Guez
G.
Fendrich
et al.
(2004)
ArticleTitleImatinib (STI571) resistance in chronic myelogenous leukemia: molecular basis of the underlying mechanisms and potential strategies for treatment
Mini Rev. Med. Chem.
4
285–299
Occurrence
Handle10.2174/1389557043487321
Occurrence
Handle1:CAS:528:DC%2BD2cXisVKhur8%3D
Occurrence
Handle15032675
Article
CAS
PubMed
Google Scholar
J.E.
Dancey
B.
Freidlin
(2003)
ArticleTitleTargeting epidermal growth factor receptor – Are we missing the mark?
Lancet
362
62–64
Occurrence
Handle10.1016/S0140-6736(03)13810-X
Occurrence
Handle1:CAS:528:DC%2BD3sXltF2is7w%3D
Occurrence
Handle12853203
Article
CAS
PubMed
Google Scholar
P.
Danzon
A.
Towse
(2002)
ArticleTitleThe economics of gene therapy and of pharmacogenetics
Value Health
5
5–13
Occurrence
Handle10.1046/j.1524-4733.2002.51081.x
Occurrence
Handle11873384
Article
PubMed
Google Scholar
E.
Eigenbrodt
M.
Reinacher
U.
Scheefers-Borchel
H.
Scheefers
R.
Friis
(1992)
ArticleTitleDouble role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells
Crit. Rev. Oncog.
3
91–115
Occurrence
Handle1:CAS:528:DyaK2cXhtVens7w%3D
Occurrence
Handle1532331
CAS
PubMed
Google Scholar
R.
Green
(2003)
ArticleTitleMystery of thiamine-responsive megaloblastic anemia unlocked
Blood
102
3464–3465
Occurrence
Handle10.1182/blood-2003-09-3025
Occurrence
Handle1:CAS:528:DC%2BD3sXptVymsLg%3D
Article
CAS
Google Scholar
J.L.
Griffin
(2004)
ArticleTitleMetabolic profiles to define the genome: can we hear the phenotypes?
Philos. Trans. R. Soc. Lond. B Biol. Sci.
359
857–871
Occurrence
Handle10.1098/rstb.2003.1411
Occurrence
Handle1:CAS:528:DC%2BD2cXmt1yms70%3D
Occurrence
Handle15306403
Article
CAS
PubMed
Google Scholar
V.
Guillemard
H.U.
Saragovi
(2004)
ArticleTitleNovel approaches for targeted cancer therapy
Curr. Cancer Drug Targets
4
313–326
Occurrence
Handle10.2174/1568009043332989
Occurrence
Handle1:CAS:528:DC%2BD2cXkvFyjsrk%3D
Occurrence
Handle15180497
Article
CAS
PubMed
Google Scholar
W.K.
Hofmann
M.
Komor
D.
Hoelzer
O.G.
Ottmann
(2004)
ArticleTitleMechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia
Leuk. Lymphoma
45
655–660
Occurrence
Handle10.1080/10428190310001625755
Occurrence
Handle1:CAS:528:DC%2BD3sXpvV2lsbw%3D
Occurrence
Handle15160936
Article
CAS
PubMed
Google Scholar
W.
Hu
J.J.
Kavanagh
(2003)
ArticleTitleAnticancer therapy targeting the apoptotic pathway
Lancet Oncol.
4
721–729
Occurrence
Handle10.1016/S1470-2045(03)01277-4
Occurrence
Handle1:CAS:528:DC%2BD3sXps1OgsL0%3D
Occurrence
Handle14662428
Article
CAS
PubMed
Google Scholar
F.P.
Kuhajda
(2000)
ArticleTitleFatty-acid synthase and human cancer: new perspectives on its role in tumor biology
Nutrition
16
202–208
Occurrence
Handle10.1016/S0899-9007(99)00266-X
Occurrence
Handle1:CAS:528:DC%2BD3cXhsFGqu7w%3D
Occurrence
Handle10705076
Article
CAS
PubMed
Google Scholar
S.
Matzku
H.
Krempel
H.P.
Weckenmann
V.
Schirrmacher
H.
Sinn
H.
Stricker
(1990)
ArticleTitleTumor targeting with antibody-coupled liposomes: failure to achieve accumulation in xenografts and spontaneous liver metastases.
Cancer Immunol. Immunother.
31
285–291
Occurrence
Handle10.1007/BF01740936
Occurrence
Handle1:STN:280:By%2BA38bmtFE%3D
Occurrence
Handle2376046
Article
CAS
PubMed
Google Scholar
E.R.
Nemecek
D.C.
Matthews
(2003)
ArticleTitleUse of radiolabeled antibodies in the treatment of childhood acute leukemia
Pediatr. Transplant.
3
89–94
Occurrence
Handle10.1034/j.1399-3046.7.s3.14.x
Article
Google Scholar
H.C.
Pitot
J.P.
Jost
(1967)
ArticleTitleControl of biochemical expression in morphologically related cells in vivo and in vitro
Natl. Cancer Inst. Monogr.
26
145–166
Occurrence
Handle1:STN:280:CCeD1M%2FlsVY%3D
Occurrence
Handle4294465
CAS
PubMed
Google Scholar
C.M.
Rudin
J.
Holmlund
G.F.
Fleming
et al.
(2001)
ArticleTitlePhase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer
Clin. Cancer Res.
7
1214–1220
Occurrence
Handle1:CAS:528:DC%2BD3MXktlemu7g%3D
Occurrence
Handle11350886
CAS
PubMed
Google Scholar
C.
Schmidt
(2004)
ArticleTitleMetabolomics takes its place as latest up-and-coming “omic” science
J. Natl. Cancer Inst.
96
732–734
Occurrence
Handle15150298
PubMed
Google Scholar
A.G.
Schwartz
L.
Pashko
J.M.
Whitcomb
(1986)
ArticleTitleInhibition of tumor development by dehydroepiandrosterone and related steroids
Toxicol. Pathol.
14
357–362
Occurrence
Handle1:CAS:528:DyaL2sXitVOruro%3D
Occurrence
Handle3024302
CAS
PubMed
Google Scholar
N.P.
Shah
C.
Tran
F.Y.
Lee
P.
Chen
D.
Norris
C.L.
Sawyers
(2004)
ArticleTitleOverriding imatinib resistance with a novel ABL kinase inhibitor
Science
305
399–401
Occurrence
Handle10.1126/science.1099480
Occurrence
Handle1:CAS:528:DC%2BD2cXls1egtrY%3D
Occurrence
Handle15256671
Article
CAS
PubMed
Google Scholar
E.L.
Sievers
(2000)
ArticleTitleTargeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates
Cancer Chemother. Pharmacol.
46
S18–S22
Occurrence
Handle1:CAS:528:DC%2BD3cXks1Oksrc%3D
Occurrence
Handle10950142
CAS
PubMed
Google Scholar
T.A.
Smith
(1998)
ArticleTitleFDG uptake, tumor characteristics and response to therapy: a review
Nucl. Med. Commun.
19
97–105
Occurrence
Handle1:CAS:528:DyaK1cXhsF2gt7g%3D
Occurrence
Handle9548192
CAS
PubMed
Google Scholar